Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	344.77	392.1	195.81	102.3	164.16	228.06
Cash & Short-Term Investments	344.77	392.1	195.81	102.3	164.16	228.06
Cash Growth	-19.30%	100.25%	91.41%	-37.68%	-28.02%	318.94%
Accounts Receivable	30.77	32.39	26.18	21.33	21.14	12.25
Other Receivables	-	0.18	-	-	-	-
Receivables	30.77	32.56	26.18	21.33	21.14	12.25
Inventory	3.49	3.04	2.31	1.97	1.25	1.2
Prepaid Expenses	7.95	13.28	7.79	4.03	4.75	3.39
Restricted Cash	-	-	0.15	-	-	-
Other Current Assets	-	-	-	-	-	1.26
Total Current Assets	386.98	440.99	232.24	129.63	191.3	246.16
Property, Plant & Equipment	22.29	15.33	18.21	17.9	11.82	13.94
Other Long-Term Assets	1.61	1.61	1.61	1.76	1.76	1.76
Total Assets	410.88	457.94	252.06	149.29	204.89	261.86
Accounts Payable	6.26	4.18	4.39	5.12	4.59	2.71
Accrued Expenses	40.27	35.12	28.67	24.1	20.12	14.31
Current Portion of Long-Term Debt	-	-	-	-	-	8.29
Current Portion of Leases	2.76	1.93	1.59	1.6	1.62	1.36
Current Unearned Revenue	-	0.13	0.26	0.58	-	-
Total Current Liabilities	49.29	41.35	34.9	31.4	26.34	26.66
Long-Term Debt	70.62	68.51	74.93	54.01	51.44	41.24
Long-Term Leases	3.63	5.35	6.88	8.68	5.92	7.55
Long-Term Unearned Revenue	14	14	14.14	13.39	13	12
Other Long-Term Liabilities	15.11	13.39	30.1	6.44	20.19	98.31
Total Liabilities	152.65	142.59	160.93	113.91	116.89	185.77
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,351	1,206	788.7	652.21	633.8	615.34
Retained Earnings	-1,092	-891.08	-697.58	-616.84	-545.8	-539.25
Shareholders' Equity	258.23	315.34	91.13	35.38	88	76.1
Total Liabilities & Equity	410.88	457.94	252.06	149.29	204.89	261.86
Total Debt	77.01	75.78	83.39	64.28	58.98	58.44
Net Cash (Debt)	267.76	316.32	112.42	38.02	105.18	169.62
Net Cash Growth	-23.95%	181.38%	195.70%	-63.86%	-37.99%	-
Net Cash Per Share	1.54	2.00	1.31	0.46	1.28	2.79
Filing Date Shares Outstanding	213.05	159.02	148.63	77.51	76.75	76.07
Total Common Shares Outstanding	174.95	157.75	114.96	77.2	76.73	76
Working Capital	337.69	399.63	197.34	98.23	164.96	219.5
Book Value Per Share	1.48	2.00	0.79	0.46	1.15	1.00
Tangible Book Value	258.23	315.34	91.13	35.38	88	76.1
Tangible Book Value Per Share	1.48	2.00	0.79	0.46	1.15	1.00
Machinery	-	18.05	16.78	13.75	12.28	11.47
Construction In Progress	-	0.12	0.28	4.07	0.58	0.12
Leasehold Improvements	-	14.53	14.7	9.07	9.07	9.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.